BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| (2->1)-beta-D-fructofuranan {Inulin} - Anaerostipes caccae |
👶
Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut (Gut ) Vol: 66 Issue 11 Pages: 1968-1974 Pub: 2017 Nov Epub: 2017 Feb 17 Authors Vandeputte D , Falony G , Vieira-Silva S , Wang J , Sailer M , Theis S , Verbeke K , Raes J , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Anaerostipes caccae |
👶
Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD Study. Kidney international reports (Kidney Int Rep ) Vol: 9 Issue 3 Pages: 671-685 Pub: 2024 Mar Epub: 2023 Dec 30 Authors Sohn MB , Gao B , Kendrick C , Srivastava A , Isakova T , Gassman JJ , Fried LF , Wolf M , Cheung AK , Raphael KL , Vinales PC , Middleton JP , Pabalan A , Raj DS , Pilot Studies in CKD Consortium , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Anaerostipes caccae |
📓
Inulin-type prebiotics reduce serum uric acid levels via gut microbiota modulation: a randomized, controlled crossover trial in peritoneal dialysis patients. European journal of nutrition (Eur J Nutr ) Vol: 61 Issue 2 Pages: 665-677 Pub: 2022 Mar Epub: 2021 Sep 7 Authors He S , Xiong Q , Tian C , Li L , Zhao J , Lin X , Guo X , He Y , Liang W , Zuo X , Ying C , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
